Impact of serotherapy on immune reconstitution and survival outcomes after stem cell transplantations in children: thymoglobulin versus alemtuzumab.

Willemsen L, van der Zijde CMJol-, Admiraal R, Putter H, Jansen-Hoogendijk AM, Dam MMOstaijen, Wijnen JT, van Kesteren C, Waaijer JLM, Lankester AC, et al. Impact of serotherapy on immune reconstitution and survival outcomes after stem cell transplantations in children: thymoglobulin versus alemtuzumab. Biol Blood Marrow Transplant. 2014.